AstraZeneca
Facts
29 propertiesIdentity
- Instance of
- business, enterprise, public company, biopharmaceutical company[4][5][6]
- Official website
- www.astrazeneca.com[36]
- Legal form
- public limited company[42]
- Official name
- AstraZeneca PLC (1999–present), Zeneca Group PLC (1993–1999)[41]
Status and dates
Location
- Headquarters location
- Cambridge, Cambridge Biomedical Campus[12][13]
- Country
- United Kingdom, Sweden[2][3]
- Located in the administrative territorial entity
- Cambridge[1]as of 2026-10-21
where from?
- Record
- ror.org/04r9x1a08
- Edition
- 20261021 · as of 2026-10-21
- Bronze
7a7bf58d5ac18436v2.15-2026-10-20-ror-data.zip- Transform
- 4ort-mint · ror:20261021 · version not recorded
Industry and activity
- Industry
- pharmaceutical industry[32]
- Product or material produced
- medication[37]
Financials
- Net profit
- 2.8B (1.2B–6.4B, n=5)
- Operating income
- 4.1B (2.9B–4.9B, n=5)
- Total assets
- 60.1B (53.4B–62.5B, n=5)
People
- Chief executive officer
- Pascal Soriot (2012–present)[14]
- Board member
- Leif Johansson, Pascal Soriot, Graham Chipchase, Geneviève Berger, Sheri McCoy, Tony Mok, Nazneen Rahman, Marcus Wallenberg
- Chairperson
- Leif Johansson (2012–present)[33]
Relations
- Owned by
- BlackRock (2009–present), Investor (2019–present), Capital Group Companies (2018–present), Wellington Management Company (2019–present)[7][8][9][10]
- Part of
- FTSE 100 Index[28]
- Child organization or unit
- AstraZeneca Canada, AstraZeneca PTY, AstraZeneca Korea, AstraZeneca AB, AstraZeneca India, AstraZeneca Oy, AstraZeneca, AstraZeneca Farmaceutica Spain S.A., AstraZeneca Czech Republic s.r.o., Cambridge Antibody Technology, AstraZeneca (United States), Amylin Pharmaceuticals, Acerta Pharma[15][16][17][18][19][20][21][22][23][24][25][26][27]
- Owner of
- Archigen Biotech, Montrose Chemical Corporation of California, ADC Therapeutics, Circassia Pharmaceuticals, Entasis Therapeutics, Moderna, PhaseBio Pharmaceuticals (United States)[43][44][45][46][47][48][49]
More facts +4
- Carbon footprint
- 6.0M (2.1k–6.9M, n=91)
- Social media followers
- 305k (143k–305k, n=4)
- Stock exchange
- New York Stock Exchange (1999–present), London Stock Exchange, Nasdaq Stockholm AB[29][30][31]
- ROR ID
- 04r9x1a08
- ISNI
- 0000000104335842⚖ sources disagree Wikidata 0000000104335842 openaire_graph 0000 0004 5929 4381 edition 2026-10-02 · CC BY 4.0BnF data 0000 0001 1519 6403 edition 2026-10-01 · fr-lo ↗
- Legal Entity Identifier
- PY6ZZQWO2IZFZC3IOL08
- VIAF cluster ID
- 154100491
- Library of Congress Authorities ID
- no2010135192⚖ sources disagree Wikidata no2010135192 isni_public n94802189 edition 2026-10-01 · CC0 1.0
- GND ID
- 10037826-2
- GRID ID
- grid.417815.e
- Image (Wikimedia Commons)
- AstraZeneca HQ in Cambridge UK.jpg ↗
- Article ID in the Lithuanian Universal Encyclopedia Online
- astrazeneca
- BBC News topic ID
- cz4pr2gd52lt
- Bibliothèque nationale de France ID
- 13548755d
- Brockhaus Enzyklopädie online ID
- astrazeneca-plc
Show all 64 identifiers +52
- CANTIC ID
- 981058513598106706
- CNA topic ID
- astrazeneca
- Central Index Key
- 0000901832
- Companies House company ID
- 02723534
- Comparably company ID
- astrazeneca-plc
- Crunchbase organization ID
- astrazeneca
- D-U-N-S number
- 230790719
- Dagens Nyheter topic ID
- astra-zeneca
- De Agostini ID
- AstraZeneca
- Described at URL
- www.fundinguniverse.com
- EU Transparency Register ID
- 249402638316-62
- FAST ID
- 1995186
- Facebook username
- astrazenecacareers
- Freebase ID
- /m/028zbs
- Glassdoor company ID
- 9214
- Golden ID (archived)
- AstraZeneca-PY54V
- Google Scholar organization ID
- 992515209104559621
- Great Russian Encyclopedia portal ID
- astrazeneca-a9c2fa
- HAND ID
- B29F-C8E9-2A1A-8075-F66E
- ISIN
- GB0009895292
- ITV News topic ID
- astra-zeneca
- IdRef ID
- 050814931
- Instagram username
- astrazeneca
- J9U entity ID
- 987011066432105171
- KISTI ID
- K000228781
- Kompass company ID
- gb99149474
- Lex ID
- AstraZeneca
- LinkedIn company or organization ID
- astrazeneca
- Medvik ID
- nlk20030129777
- Microsoft Academic ID (discontinued)
- 105036370
- NE.se ID
- astrazeneca-plc
- NL CR AUT ID
- nlk20030129777
- National Library of Portugal ID
- 1468281
- Open Funder Registry funder ID
- 100004325
- OpenCorporates organization ID
- gb/02723534
- OpenParliamentTV organization ID
- AstraZeneca
- PermID
- 4295894341
- Quora topic ID
- AstraZeneca
- SVKKL authority ID
- 0446640-AstraZeneca
- Scilit organization ID
- 10524
- The Guardian topic ID
- business/astrazeneca
- Threads username
- astrazeneca
- Topic's main category
- Category:AstraZeneca
- Treccani ID
- astrazeneca
- UK Parliament thesaurus ID
- 2690
- University of Barcelona authority ID
- 981058513598106706
- Vedomosti company ID
- astrazeneca-
- Wellcome Collection concept ID
- as8efjxt
- Wikirate Company ID
- 47630
- X (Twitter) username
- AstraZeneca (2009–present)
- Yale LUX ID
- group/bc7a5ea2-8186-4c44-8dd4-18b8e1c46d85
- OpenAlex CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
- ROR (Research Organization Registry)
From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.
← Affiliated with 18
Employees / affiliates 9
← Parent organization or unit 5
Board member 4
Belongs to 3
Child organization or unit 3
Instance of 3
Stock exchange 3
Country 2
Headquarters location 2
Owner of 2
Chairperson 1
Chief executive officer 1
Different from 1
Follows 1
Industry 1
Location of formation 1
Part of 1
Preceded by (successor) 1
Product or material produced 1
Topic's main category 1
← Category's main topic 1
← Developer 1
← FactGrid item ID 1
← Manufacturer 1
← Sponsor 1
0 sources
high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.
evidence “AstraZeneca ( AZN, AZN,AZN.L, AZN,AZN.L,AZN.ST, AZN,AZN.L,AZN.ST,ZEG.DE,ZEG.DE,AZN.ST,ZEG.DE) and Daiichi Sankyo announced that the European Commission has approved Enhertu in combination with Pertuzumab for the treatment of adult patients with HER2-positive metastatic breast cancer.” rttnews.com · read source
evidence “AstraZeneca targets growth through oncology pipeline” finance.yahoo.com · 2026-10-14 · read source
evidence “The FTSE 100 was grumpy, with HSBC, Shell, AstraZeneca and British American Tobacco among the names weighing the market down.” cityam.com · read source
evidence “Drug giant AstraZeneca has invested two billion US dollars (£1.5 billion) in US pharmaceutical firm Summit Therapeutics as part of a cancer treatment research joint venture.” warringtonguardian.co.uk · read source
evidence “AstraZeneca (LSE/STO/NYSE:” investegate.co.uk · read source
Show 10 low-confidence claims
Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.
evidence “Adesua is Chief Financial Officer of +OSB, a Canadian manufacturer based in Burlington and previously held senior finance roles at Fusion Pharmaceuticals, which was acquired by AstraZeneca, and Phillips 66 Canada.” newswire.ca · read source
evidence “Through this agreement, AstraZeneca has acquired worldwide rights to develop and commercialise Zegfrovy.” miragenews.com · read source
evidence “The approval also carries financial implications, triggering $100 million milestone payment from AstraZeneca to Daiichi Sankyo under their collaboration agreement.” rttnews.com · read source
evidence “AstraZeneca (NYSE:AZN) today announced the successful completion of the previously announced exclusive license agreement with Dizal Pharmaceutical Co., Ltd for ZEGFROVY® (sunvozertinib), an oral irreversible epidermal growth factor receptor (EGFR) inhibitor for patients with lung cancer.” baystreet.ca · read source
evidence “AstraZeneca (LSE/STO/NYSE:” investegate.co.uk · read source
evidence “The FTSE 100 was grumpy, with HSBC, Shell, AstraZeneca and British American Tobacco among the names weighing the market down.” cityam.com · read source
evidence “Biopharmaceutical firm AstraZeneca Philippines and Ayala Healthcare Holdings Inc.” bworldonline.com · read source
evidence “Shoamanesh has reported consulting/advisory, speaking, and/or research relationships with multiple pharmaceutical and biotechnology companies, including Daiichi Sankyo, Bayer, AstraZeneca, Bristol Myers Squibb/Pfizer, Servier, and others, as well as research support from governmental and nonprofit organizations.” medscape.com · read source
evidence “The ISS National Lab has supported a variety of investigations from global pharmaceutical companies, including Merck & Co., AstraZeneca, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Sanofi, and others.” prnewswire.com · read source
evidence “BenevolentAI has collaborated with pharma giant AstraZeneca and in 2020 helped identify Baricitinib, a drug used to treat rheumatoid arthritis, as a potential treatment for Covid-19.” dailymail.com · read source